Royalty Pharma (RPRX)
undefined
undefined%
At close: undefined
25.84
0.02%
After-hours Jan 03, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 2.35B 2.24B 2.29B 2.12B 1.81B 1.79B 1.60B 1.88B 1.65B
Cost of Revenue 560.66M 5.67M 23.00M 88.11M 1.02B 135.96M 33.27M n/a n/a
Gross Profit 1.79B 2.23B 2.27B 2.03B 794.93M 1.66B 1.56B 1.88B 1.65B
Operating Income 1.49B 977.50M 1.43B 1.59B 2.62B 1.36B 939.69M 722.87M 794.28M
Interest Income 72.29M 78.33M 53.53M 28.38M 22.33M 24.44M 6.76M n/a n/a
Pretax Income 1.70B 230.06M 1.24B 1.70B 2.46B 1.52B 1.34B 761.89M 758.71M
Net Income 1.13B 42.83M 478.75M 495.20M 2.35B 1.38B 1.21B 565.91M 581.43M
Selling & General & Admin 249.75M 227.30M 182.83M 182.00M 103.44M 61.91M 106.44M 69.51M 121.42M
Research & Development 52.00M 177.11M 200.08M 26.00M 83.04M 392.61M 117.87M 91.02M 98.38M
Other Expenses n/a 909.91M 475.84M 319.00M -995.40M -1.52M -1.62M -925.80M -570.18M
Operating Expenses 862.40M 1.31B 858.75M 527.00M -808.92M 430.45M 658.24M 1.09B 789.98M
Interest Expense 187.19M 187.96M 166.14M 157.00M 268.57M 279.96M 247.34M 238.91M 224.42M
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 862.40M 1.31B 858.75M 527.00M -808.92M 430.45M 658.24M 1.15B 858.14M
Income Tax n/a 187.23M 762.45M 1.15B 349.33M 433.37M 542.65M 195.99M 177.28M
Shares Outstanding (Basic) 447.60M 437.96M 414.79M 375.44M 365.90M 354.18M 354.18M 607.04M 607.04M
Shares Outstanding (Diluted) 602.90M 437.97M 414.80M 375.45M 365.90M 354.18M 354.18M 607.04M 607.04M
EPS (Basic) 3.41 0.10 1.15 1.32 6.42 3.89 3.42 0.93 0.96
EPS (Diluted) 2.53 0.10 1.15 1.32 6.42 3.89 3.42 0.93 0.96
EBITDA 1.89B 928.56M 1.45B 1.68B 2.65B 1.40B 972.96M 1.07B 862.44M
Depreciation & Amortization 395.13M 5.67M 23.00M 23.06M 23.92M 33.27M 33.27M 68.20M 68.16M